Cargando…
DCcov: Repositioning of drugs and drug combinations for SARS-CoV-2 infected lung through constraint-based modeling
The 2019 coronavirus disease (COVID-19) became a worldwide pandemic with currently no approved effective antiviral drug. Flux balance analysis (FBA) is an efficient method to analyze metabolic networks. Here, FBA was applied on human lung cells infected with severe acute respiratory syndrome coronav...
Autores principales: | Kishk, Ali, Pacheco, Maria Pires, Sauter, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536485/ https://www.ncbi.nlm.nih.gov/pubmed/34723158 http://dx.doi.org/10.1016/j.isci.2021.103331 |
Ejemplares similares
-
Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020) -
Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2
por: Fan, Shiyong, et al.
Publicado: (2020) -
Polypharmacology guided drug repositioning approach for SARS-CoV2
por: Jamir, Esther, et al.
Publicado: (2023) -
Identifying Effective Antiviral Drugs Against SARS-CoV-2 by Drug Repositioning Through Virus-Drug Association Prediction
por: Peng, Lihong, et al.
Publicado: (2020) -
Recent computational drug repositioning strategies against SARS-CoV-2
por: Lu, Lu, et al.
Publicado: (2022)